Watchlist
ODD · ODDITY Tech Ltd.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 18 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Resolved Graded and closed 2026-09-11 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-20 and is not part of the scored record.
Current thesis
Broken compounder with exactly one dated event: the 2026-09-09 pre-market Q2 print. Price ran $13.22 (2026-08-21) to $14.35 (2026-08-28) on no company disclosure since 2026-07-22, leaving it ~30% above the $11.07 consensus target of 10 analysts with RSI(14) at 61.9 into a gap that resolves first-order trend, CPA direction and the FY2026 adjusted-EBITDA guide.
Kill line
A weekly close below $13 abandons the shelf the 2026-08-21 close of $13.22 defended and re-opens the ~$9.25 July bounce origin; secondary condition: the 2026-09-09 Q2 print shows first orders still down more than 40% YoY with CPA unimproved, or the FY2026 positive-adjusted-EBITDA guide is cut or withdrawn.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for ODD —
As of 20 September 2026, the latest FrontierPicks analysis for ODDITY Tech Ltd. (ODD): Broken compounder with exactly one dated event: the 2026-09-09 pre-market Q2 print. Price ran $13.22 (2026-08-21) to $14.35 (2026-08-28) on no company disclosure since 2026-07-22, leaving it ~30% above the $11.07 consensus target of 10 analysts with RSI(14) at 61.9 into a gap that resolves first-order trend, CPA direction and the FY2026 adjusted-EBITDA guide.
Kill line: A weekly close below $13 abandons the shelf the 2026-08-21 close of $13.22 defended and re-opens the ~$9.25 July bounce origin; secondary condition: the 2026-09-09 Q2 print shows first orders still down more than 40% YoY with CPA unimproved, or the FY2026 positive-adjusted-EBITDA guide is cut or withdrawn.
Current Thesis
ODDITY Tech’s recovery thesis depends on delivering its September 9 third-quarter outlook before a weekly close below $14.35 erases the pre-results price reference. The next results must establish whether the advertising disruption is easing enough to sustain the earnings recovery.
The narrative is maturing — an inference from the September 18, 2026 adjusted close of $18.11, below September 11’s $18.28 despite continuing estimate-revision coverage. Zacks published another earnings-revision article on September 15; that establishes continued attention, not broader participation. The limited price observations do not establish a new trend. Zacks, September 15
The substantive change since the September 13 assessment is continued analyst disagreement. Stock Analysis records Goldman Sachs raising its target to $9 from $8 on September 14 while retaining its negative rating. Its September 14 consensus update gives a $14.93 average target across 10 analysts, below the September 18 market close. These are third-party forecasts, not measured company value. Analyst revisions
Bullish and bearish views on ODDITY Tech Ltd.
The model's bull view on ODDITY Tech Ltd. (ODD), in brief: Earnings recovered ahead of guidance. The September 9 release reported second-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $13 million against the $8–10 million guidance range. Third-quarter guidance calls for revenue down… The bear view: Repeat revenue still deteriorated. The September 13 assessment recorded second-quarter repeat-order revenue down approximately 20%, as disclosed September 9, versus the first quarter’s approximately 15% decline. That comparison is consistent with management’s explanation that… Both cases follow in full.
Bull Case
- Earnings recovered ahead of guidance. The September 9 release reported second-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $13 million against the $8–10 million guidance range. Third-quarter guidance calls for revenue down approximately 5% year over year and adjusted EBITDA of $18–20 million; missing that outlook would undermine the recovery case. Company results
- Acquisition deterioration has moderated. The September 13 published assessment recorded management’s September 9 disclosure that second-quarter first-order revenue fell approximately 40% year over year, compared with the approximately 50% decline reported for the first quarter on June 2. This supports stabilization only; renewed deterioration in the next reported first-order figure would contradict that interpretation.
- Analysts acknowledged the improved outlook. Benzinga records Truist increasing its target to $18 from $16 and Evercore ISI increasing its target to $21 from $15 on September 10, without changing their Hold and In-Line ratings. Those revisions document reduced pessimism, not endorsement of a completed recovery. Benzinga analyst actions
Bear Case
- Repeat revenue still deteriorated. The September 13 assessment recorded second-quarter repeat-order revenue down approximately 20%, as disclosed September 9, versus the first quarter’s approximately 15% decline. That comparison is consistent with management’s explanation that earlier acquisition shortfalls reduced subsequent repeat sales.
- Advertising repair remains unquantified. Management’s September 9 remarks, as recorded in the September 13 assessment, described cost per acquisition (CPA) as still sharply elevated. The available disclosure supplied no quantified normalization threshold, leaving price strength insufficient evidence of operational repair.
- Liquidity coexists with substantial debt. The September 9 release reported $561 million of cash, equivalents and investments at June 30, 2026, and approximately $550 million of remaining exchangeable-note principal after the June retirement. Gross liquidity alone does not describe the financing position. Company results
Setup & Price Structure
The adjusted market series records a September 18, 2026 close of $18.11, a three-month price increase of 47.1%, and a 14-day relative strength index (RSI) of 65.4. The shares remained 71.1% below the contemporaneous 52-week high of $62.72. The August 28 close of $14.35 is the published pre-results reference used for thesis invalidation; the available observations do not establish it as repeatedly tested support.
Attention clustered around Benzinga’s September 9 squeeze and earnings coverage, September 10 analyst revisions, and Zacks’s September 15 estimate-revision article. The available evidence contains no current quantified short interest, securities-borrow cost or moving-average series. It therefore cannot establish squeeze persistence, crowded ownership or distance above a rising average. September analyst actions, September 15 coverage
Catalyst Calendar (next 30 days)
- 2026-09-20 through 2026-10-20: No company-confirmed earnings release or investor event was identified for this window on the investor-relations calendar checked September 20. September 9 is a completed event, not an upcoming catalyst. Company calendar
- 2026-09-30: The fiscal third quarter ends, according to the September 9 outlook. This closes the operating period against which guidance will be assessed; it is not an announced disclosure date. The next results release remains undated in the verified calendar. Company outlook
What Would Change Our Mind
Loss of the pre-results price reference would break the market component of the recovery case: a weekly close below $14.35 would breach the August 28, 2026 reference close. Operationally, third-quarter results missing the September 9 revenue and adjusted-EBITDA outlook would invalidate the proposed stabilization even if the price condition had not fired.
The case would play out if the next third-quarter release meets that outlook before the published price condition fires. The absence of a confirmed release date limits calendar precision; it does not turn the already completed September earnings event into a future test.
Correlation Notes
The September 20 Consumer discretionary rotation record classifies the group containing ODD, ANF, VRA and AOUT as maturing, following an accelerating classification on September 13. That is a coverage classification, not a measured return correlation, and the short sequence supports no statistical claim about shared performance.
ODDITY’s company-specific dependency remains advertising acquisition efficiency, as described in management’s September 9 remarks. A warmer consumer cluster would not resolve continued first-order contraction or worsening repeat revenue; those operating disclosures, rather than the group label, determine whether the recovery thesis survives.
Notes
- Foreign private issuer (Israel): reports via 6-K/20-F, not 10-Q — quarterly detail is thinner than a US domestic filer's.
- Dual-class structure: listed Class A versus founder-held Class B super-voting shares; public holders do not control the vote.
- Reporting cadence slipped twice in 2026 — Q1 to 2026-06-02 from an early-May pattern, Q2 to 2026-09-09 versus 2025-08-04 for Q2 2025.
- Buyback authorization had $167.3M remaining as of the Q1 2026 report; the issuer is an active bidder in its own Class A stock.
- The 'largest advertising partner' behind the CPA blowout has never been named by the company, so the claim cannot be cross-checked externally.
- Consensus-target screens disagree materially post-crash (from $8 to stale figures above $60); the named post-Q1 targets are the checkable set.
Related · shared themes
CRSR
Corsair Gaming, Inc.
Corsair Gaming's margin-recovery story is approaching its $14.35 annual high; a weekly close above that level would confirm the recovery leg. A weekly close below the market's $10.93 August anchor would invalidate it, while the next quarterly report tests whether profitability persists beyond the tariff benefit.
HNST
The Honest Company, Inc.
The Honest Company’s margin re-rating depends on Q3 confirming organic growth and profitability excluding tariff refunds. Confirmation requires organic growth of at least 5%, underlying adjusted gross margin of at least 43.8% and unchanged annual guidance before a weekly close below $5.00 invalidates the structure.
IBTA
Ibotta, Inc.
Ibotta's rally prices a repeatable recovery in digital-promotions revenue; Q3 revenue above $86 million with year-over-year growth would confirm the next leg, unless a weekly close below $33 invalidates it first.
ANF
Abercrombie & Fitch Co.
Abercrombie & Fitch’s margin re-rating lacks price confirmation after the 2026-09-18 close of $135.76. Continuation requires a weekly close above $152.08 before Q3 results, estimated for 2026-11-24, without first closing below $130.
See also · stocks to watch